Moneycontrol
Get App
Last Updated : Aug 18, 2012 03:13 PM IST | Source: Moneycontrol.com

Buy Cravatex; target Rs 682: Angel Broking

Angel Broking is bullish on Cravatex and has recommended buy rating on the stock with a target price of Rs 682 in its August 16, 2012 research report.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Angel Broking is bullish on Cravatex and has recommended buy rating on the stock with a target price of Rs 682 in its August 16, 2012 research report.


“Cravatex Ltd (Cravatex) reported a poor set of numbers for 1QFY2013. Its top-line came in 30.8% higher at Rs 57cr, in line with our estimate of Rs 59cr. The rise in the top-line was on account of a healthy growth of 60% in domestic sales which compensated for the revenue dip of 37% from the international segment. The EBITDA for the quarter dipped marginally by 0.8% yoy and came in at Rs 2.7cr, lower than our estimate of Rs 3cr. Operating margin contracted by 149bp mainly on account of 99bp yoy increase in other expenses. Consequently, the net profit for the quarter was lower by 15% yoy at Rs 1.6cr, against our estimates of Rs 2.4cr.


The company has recently signed two new exclusive fitness equipment distribution agreements with Polar Electro OY (Finland) and Miha Body Tec (Germany). It has also further extended its distribution agreement with Johnson till 2025. The company continues to provide high-quality equipment and customer service to reputed health club chains such as Talwalkars and Gold’s Gym. It continues to broaden its presence in India, UK, Ireland and Europe through FILA, a 100-year old Italian sportswear brand. FILA plans to set up 60-70 stores across India by 2014 and be present in almost all large retail formats such as Shoppers Stop, Westside and Lifestyle.


On the back of the above developments, Cravatex’ net revenue is expected to grow at a CAGR of 18.9% over FY2012-14E to Rs 340cr. The EBITDA is expected to be Rs 20cr while the margin is expected to rebound to 6% in FY2014E. The net profit is to post a CAGR of 26% to Rs 15cr in FY2014E. At the current market price of Rs 507, the stock is trading at an attractive valuation of 8.9x PE FY2014E earnings. We continue to recommend Buy on Cravatex with a revised target price of Rs 682 based on a target PE of 12x for FY2014E,” says Angel Broking research report.


Non-Institutions holding more than 90% in Indian cos


Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.


To read the full report click on the attachment



Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Aug 18, 2012 03:11 pm
Sections
Follow us on